GPC3 and hepatocellular carcinoma: A recently published first-in-human study evaluated a synthetic peptide ligand, namely 68Ga-RAYZ-8009, for GPC3-targeted imaging in 24 patients (22 adults with suspected or confirmed HCC and 2 children with hepatoblastoma) [30].